Table of Contents Chapter 1 Overview of Bioengineered Protein Drugs 1.1 Definition of Bioengineered Protein Drugs in This Report 1.2 Commercial Types of Bioengineered Protein Drugs 1.2.1 Therapeutic Proteins 1.2.2 Monoclonal Antibodies 1.2.3 Vaccines 1.3 Downstream Application of Bioengineered Protein Drugs 1.3.1 Diabetes and Hormonal Disorders 1.3.2 Genetic and Fertility Disorders 1.3.3 Cancers 1.3.4 Organ Transplants 1.3.5 Others 1.4 Development History of Bioengineered Protein Drugs 1.5 Market Status and Trend of Bioengineered Protein Drugs 2013-2023 1.5.1 Global Bioengineered Protein Drugs Market Status and Trend 2013-2023 1.5.2 Regional Bioengineered Protein Drugs Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Bioengineered Protein Drugs 2013-2017 2.2 Production Market of Bioengineered Protein Drugs by Regions 2.2.1 Production Volume of Bioengineered Protein Drugs by Regions 2.2.2 Production Value of Bioengineered Protein Drugs by Regions 2.3 Demand Market of Bioengineered Protein Drugs by Regions 2.4 Production and Demand Status of Bioengineered Protein Drugs by Regions 2.4.1 Production and Demand Status of Bioengineered Protein Drugs by Regions 2013-2017 2.4.2 Import and Export Status of Bioengineered Protein Drugs by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Bioengineered Protein Drugs by Types 3.2 Production Value of Bioengineered Protein Drugs by Types 3.3 Market Forecast of Bioengineered Protein Drugs by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Bioengineered Protein Drugs by Downstream Industry 4.2 Market Forecast of Bioengineered Protein Drugs by Downstream Industry Chapter 5 Market Driving Factor Analysis of Bioengineered Protein Drugs 5.1 Global Economy Situation and Trend Overview 5.2 Bioengineered Protein Drugs Downstream Industry Situation and Trend Overview Chapter 6 Bioengineered Protein Drugs Market Competition Status by Major Manufacturers 6.1 Production Volume of Bioengineered Protein Drugs by Major Manufacturers 6.2 Production Value of Bioengineered Protein Drugs by Major Manufacturers 6.3 Basic Information of Bioengineered Protein Drugs by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Bioengineered Protein Drugs Major Manufacturer 6.3.2 Employees and Revenue Level of Bioengineered Protein Drugs Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Bioengineered Protein Drugs Major Manufacturers Introduction and Market Data 7.1 Abbott Laboratories 7.1.1 Company profile 7.1.2 Representative Bioengineered Protein Drugs Product 7.1.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Abbott Laboratories 7.2 F. Hoffmann-La Roche Ltd 7.2.1 Company profile 7.2.2 Representative Bioengineered Protein Drugs Product 7.2.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd 7.3 Amgen, Inc. 7.3.1 Company profile 7.3.2 Representative Bioengineered Protein Drugs Product 7.3.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Amgen, Inc. 7.4 Bayer AG 7.4.1 Company profile 7.4.2 Representative Bioengineered Protein Drugs Product 7.4.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Bayer AG 7.5 Merck & Co., Inc. 7.5.1 Company profile 7.5.2 Representative Bioengineered Protein Drugs Product 7.5.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Merck & Co., Inc. 7.6 Dr. Reddy's Laboratories Ltd. 7.6.1 Company profile 7.6.2 Representative Bioengineered Protein Drugs Product 7.6.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Dr. Reddy's Laboratories Ltd. 7.7 Biocon Ltd. 7.7.1 Company profile 7.7.2 Representative Bioengineered Protein Drugs Product 7.7.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Biocon Ltd. 7.8 Eli Lilly and Company 7.8.1 Company profile 7.8.2 Representative Bioengineered Protein Drugs Product 7.8.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly and Company 7.9 Sanofi 7.9.1 Company profile 7.9.2 Representative Bioengineered Protein Drugs Product 7.9.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Sanofi 7.10 GlaxoSmithKline plc 7.10.1 Company profile 7.10.2 Representative Bioengineered Protein Drugs Product 7.10.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline plc 7.11 Johnson & Johnson 7.11.1 Company profile 7.11.2 Representative Bioengineered Protein Drugs Product 7.11.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson 7.12 JanssenNovartis AG 7.12.1 Company profile 7.12.2 Representative Bioengineered Protein Drugs Product 7.12.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of JanssenNovartis AG 7.13 Panacea Biotec 7.13.1 Company profile 7.13.2 Representative Bioengineered Protein Drugs Product 7.13.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Panacea Biotec 7.14 ProBioGen AG 7.14.1 Company profile 7.14.2 Representative Bioengineered Protein Drugs Product 7.14.3 Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of ProBioGen AG Chapter 8 Upstream and Downstream Market Analysis of Bioengineered Protein Drugs 8.1 Industry Chain of Bioengineered Protein Drugs 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Bioengineered Protein Drugs 9.1 Cost Structure Analysis of Bioengineered Protein Drugs 9.2 Raw Materials Cost Analysis of Bioengineered Protein Drugs 9.3 Labor Cost Analysis of Bioengineered Protein Drugs 9.4 Manufacturing Expenses Analysis of Bioengineered Protein Drugs Chapter 10 Marketing Status Analysis of Bioengineered Protein Drugs 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Therapeutic Proteins Table Advantage and Disadvantage of Monoclonal Antibodies Table Advantage and Disadvantage of Vaccines Table Production Volume of Bioengineered Protein Drugs by Regions 2013-2017 Table Production Value of Bioengineered Protein Drugs by Regions 2013-2017 Table Demand Volume of Bioengineered Protein Drugs by Regions 2013-2017 Table Production and Demand Status of Bioengineered Protein Drugs in Region One 2013-2017 Table Production and Demand Status of Bioengineered Protein Drugs in Region Two 2013-2017 Table Production and Demand Status of Bioengineered Protein Drugs in Region Three 2013-2017 Table Production and Demand Status of Bioengineered Protein Drugs in Region Four 2013-2017 Table Import Volume of Bioengineered Protein Drugs by Regions 2013-2017 Table Export Volume of Bioengineered Protein Drugs by Regions 2013-2017 Table Production Volume of Bioengineered Protein Drugs by Types 2013-2017 Table Production Value of Bioengineered Protein Drugs by Types 2013-2017 Table Production Volume Forecast of Bioengineered Protein Drugs by Types 2018-2023 Table Production Value Forecast of Bioengineered Protein Drugs by Types 2018-2023 Table Demand Volume of Bioengineered Protein Drugs by Downstream Industry 2013-2017 Table Demand Volume Forecast of Bioengineered Protein Drugs by Downstream Industry 2018-2023 Table Production Volume of Bioengineered Protein Drugs by Major Manufacturers 2013-2017 Table Production Value of Bioengineered Protein Drugs by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Bioengineered Protein Drugs Major Manufacturer Table Employees and Revenue Level of Bioengineered Protein Drugs Major Manufacturer Table Representative Bioengineered Protein Drugs Product One of Abbott Laboratories Table Representative Bioengineered Protein Drugs Product Two of Abbott Laboratories Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Abbott Laboratories 2013-2017 Table Representative Bioengineered Protein Drugs Product One of F. Hoffmann-La Roche Ltd Table Representative Bioengineered Protein Drugs Product Two of F. Hoffmann-La Roche Ltd Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd 2013-2017 Table Representative Bioengineered Protein Drugs Product One of Amgen, Inc. Table Representative Bioengineered Protein Drugs Product Two of Amgen, Inc. Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Amgen, Inc. 2013-2017 Table Representative Bioengineered Protein Drugs Product One of Bayer AG Table Representative Bioengineered Protein Drugs Product Two of Bayer AG Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Bayer AG 2013-2017 Table Representative Bioengineered Protein Drugs Product One of Merck & Co., Inc. Table Representative Bioengineered Protein Drugs Product Two of Merck & Co., Inc. Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Merck & Co., Inc. 2013-2017 Table Representative Bioengineered Protein Drugs Product One of Dr. Reddy's Laboratories Ltd. Table Representative Bioengineered Protein Drugs Product Two of Dr. Reddy's Laboratories Ltd. Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Dr. Reddy's Laboratories Ltd. 2013-2017 Table Representative Bioengineered Protein Drugs Product One of Biocon Ltd. Table Representative Bioengineered Protein Drugs Product Two of Biocon Ltd. Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Biocon Ltd. 2013-2017 Table Representative Bioengineered Protein Drugs Product One of Eli Lilly and Company Table Representative Bioengineered Protein Drugs Product Two of Eli Lilly and Company Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly and Company 2013-2017 Table Representative Bioengineered Protein Drugs Product One of Sanofi Table Representative Bioengineered Protein Drugs Product Two of Sanofi Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017 Table Representative Bioengineered Protein Drugs Product One of GlaxoSmithKline plc Table Representative Bioengineered Protein Drugs Product Two of GlaxoSmithKline plc Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline plc 2013-2017 Table Representative Bioengineered Protein Drugs Product One of Johnson & Johnson Table Representative Bioengineered Protein Drugs Product Two of Johnson & Johnson Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017 Table Representative Bioengineered Protein Drugs Product One of JanssenNovartis AG Table Representative Bioengineered Protein Drugs Product Two of JanssenNovartis AG Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of JanssenNovartis AG 2013-2017 Table Representative Bioengineered Protein Drugs Product One of Panacea Biotec Table Representative Bioengineered Protein Drugs Product Two of Panacea Biotec Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of Panacea Biotec 2013-2017 Table Representative Bioengineered Protein Drugs Product One of ProBioGen AG Table Representative Bioengineered Protein Drugs Product Two of ProBioGen AG Table Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin of ProBioGen AG 2013-2017